Keywords: Takeda, Lundbeck, Vortioxetine, Brintillix, Janssen, Johnson & JOhnson, Canagliflozin, Metformin, Sucampo, Rescula, USA, FDA

Regulatory briefs on vortioxetine, canagliflozin/metformin combo and Rescula

Article | 13 December 2012

Print This

Takeda Global Research & Development Center, a unit of Japanese drug giant Takeda Pharma’s (TYO: 4502), and Denmark’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in